Since 2012, a series of U.S. Supreme Court decisions related to Section 101 have left innovators in the biotechnology and software industries unable to secure patent protections for many of their inventions. Since patents play a critical role in driving innovation, these decisions have potentially far-reaching implications for the U.S. economy.
To shed light on this issue, and on possible solutions, Inventing America and IPWatchdog will host a conference on Section 101, with remarks by U.S. Senator Chris Coons (D-DE) and panel discussions on the impacts of the judicial interpretations and the corrections needed from policymakers. Participants will include industry leaders and patent law experts.
The conference will take place on Wednesday, December 7, 2016, from 8am to 12pm ET, at the offices of Covington & Burlington LLP in Washington, DC. Space is limited. If you would like to attend please RSVP to email@example.com.
- U.S. Senator Chris Coons (D-DE)
- Jeff Birchak, Associate General Counsel and VP, Fallbrook Technologies
- Dr. Ananda M. Chakrabarty, Distinguished University Professor, University of Illinois College of Medicine at Chicago
- Valerie Gaydos, Founder, Angel Venture Forum
- David Kappos, Former Director, USPTO
- Former U.S. Senator Jon Kyl (R-AZ)
- Jeff Lefstin, Professor, University of California Hastings College of Law
- Amy Mills, Vice President for Intellectual Property, Juno Therapeutics
- Robert P. Taylor, Founder, RPT Legal Strategies PC
- Henry Hadad, SVP & Deputy General Counsel of IP, Bristol-Myers Squibb
- Honorable Paul Michel, Former Chief Judge, U.S. Court of Appeals for the Federal Circuit
- Adam Mossoff, Professor, Antonin Scalia Law School at George Mason University
- Ami Patel Shah, Managing Director, Fortress Investment Group
- Marian Underweiser, Senior Counsel – IBM Research IP Law, IBM
- Gene Quinn, Patent Attorney, IPWatchdog.com
Covington & Burlington LLP
850 10th Street NW
Washington, DC 20268